Clinical Trials Browser

Phase 2 × Epirubicin × Dermatologic × Clear all

NCT00755976 2014-12-31

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma